摘要
目的探讨全胸腔镜肺叶切除治疗非小细胞肺癌的可行性及安全性。方法选择2009年9月至2012年12月确诊的肺癌患者23例,男18例,女5例。年龄21~79岁,平均55.3岁。鳞癌17例,类癌1例,腺鳞癌2例.腺癌3例。IB期13例,IIA期4例,IIB期6例。行袖式支气管肺叶切除ll例,复合肺叶切除3例.合并肺动脉成形7例。结果全组均手术顺利,无围手术期死亡。采用间断吻合5例,吻合时间为62。85min。平均72.6min。连续吻合间断加固6例,吻合时间为33~42min,平均37.2min。全组术中出血100~900m1.平均420ml。每例患者清扫淋巴结17-24个,平均19.4个。胸腔闭式引流3—7d,平均5.0d。术后病理:支气管断端均未查见癌残留。结论全胸腔镜复杂肺叶切除术治疗早期非小细胞肺癌具有可行性,但远期疗效需进一步l临床试验证实。
Objective To summarize the outcomes of 23 cases of non-small cell lung cancer (NSCLC) treated with complete video-assisted thoracoscopic complex lobectomy in Beijing Chest Hospital, and to evaluate the Feasibility and safety of this procedure in VATs lobectomy. Methods Between 2009 and 2012, 23 cases of non-small cell lung cancer that has be treated with complex procedure in VATS lobectomy were reviewed. Eighteen patients were male, 5 were female. The median age was 55.3 years(21-79 years). Among these patients, 11 were underwent sleeve lobeetomy(including 3 right upper lobes, 1 right middle lobes, 3 right lower lobes, 3 left upper lobes, 1 left lower lobes), 5 bilateral lobectomy and 7 angioplasty. Seventeen patients had squamous carcinoma, 2 eases were adenosquamous carcinoma, 3 cases were adenocarcinoma, 1 case was careinoid. Thirteen cases were in stage IB, 4 cases were in stage IIA, 6 cases were in stage of liB. The operation procedure was complete VATS ]obectomy combined with systemic lymph node resection. Results All procedures were carried out smoothly without serious complications. The average duration of suture in interrupted suture group was 72.6 minutes (62-85 minutes). The duration of operation in continuous suture plus interrupted suture group was 37.2 minutes (33-42 minutes). The average blood loss was 420 m1(100-900 ml). The median number of lymph nodes dissected was 16.9(17-24). The median duration of postoperative chest tube drainage placement was 5 days(3-7 days). Conclusion Completely Video-assisted thoracoscopic complex lobectomy procedure is safe and effective in treating patients with early stage non-small cell lung cancer.
出处
《北京医学》
CAS
2013年第9期751-753,共3页
Beijing Medical Journal
基金
首都临床特色应用研究(Z111107058811087)